Menu Search
Equities

Baxter International Inc

BAX:NYQ

Baxter International Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)40.23
  • Today's Change-0.70 / -1.71%
  • Shares traded55.00
  • 1 Year change-11.47%
  • Beta0.6398
Data delayed at least 15 minutes, as of Apr 26 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
Select bar for recommendation details.
Recommendations18-Apr-24
Buy1
Outperform3
Hold12
Underperform0
Sell0

Share price forecast in USD

The 12 analysts offering 12 month price targets for Baxter International Inc have a median target of 44.50, with a high estimate of 54.00 and a low estimate of 39.00. The median estimate represents a 10.61% increase from the last price of 40.23.
High34.2%54.00
Med10.6%44.50
Low-3.1%39.00

Dividends in USD

In 2023, Baxter International Inc reported a dividend of 1.16 USD, which represents a 0.87% increase over last year. The 6 analysts covering the company expect dividends of 1.26 USD for the upcoming fiscal year, an increase of 8.19%.
Div growth (TTM)0.87%
More ▼

Earnings history & estimates in USD

On Feb 08, 2024, Baxter International Inc reported 4th quarter 2023 earnings of 0.88 per share. This result was in line with the consensus of the 13 analysts following the company and was the same as last year's 4th quarter results.
The next earnings announcement is expected on May 02, 2024.
Average growth rate+5.24%
Baxter International Inc reported annual 2023 earnings of 2.60 per share on Feb 08, 2024.
Average growth rate-4.64%
More ▼

Revenue history & estimates in USD

Baxter International Inc. had 4th quarter 2023 revenues of 3.89bn. This bettered the 3.80bn consensus of the 12 analysts covering the company. This was 4.80% above the prior year's 4th quarter results.
Average growth rate+0.07%
Baxter International Inc. had revenues for the full year 2023 of 14.81bn. This was 1.99% below the prior year's results.
Average growth rate+7.12%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.